BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26551724)

  • 1. Liver X receptors in immune cell function in humans.
    Waddington KE; Jury EC; Pineda-Torra I
    Biochem Soc Trans; 2015 Aug; 43(4):752-7. PubMed ID: 26551724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver X receptor in cholesterol metabolism.
    Zhao C; Dahlman-Wright K
    J Endocrinol; 2010 Mar; 204(3):233-40. PubMed ID: 19837721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptors contribute to periodontal pathogen-elicited inflammation and oral bone loss.
    Huang N; Shaik-Dasthagirisaheb YB; LaValley MP; Gibson FC
    Mol Oral Microbiol; 2015 Dec; 30(6):438-50. PubMed ID: 25946408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.
    Xiao L; Xie X; Zhai Y
    Adv Drug Deliv Rev; 2010 Oct; 62(13):1316-21. PubMed ID: 20659512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity.
    Kidani Y; Bensinger SJ
    Immunol Rev; 2012 Sep; 249(1):72-83. PubMed ID: 22889216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptors as regulators of macrophage inflammatory and metabolic pathways.
    A-González N; Castrillo A
    Biochim Biophys Acta; 2011 Aug; 1812(8):982-94. PubMed ID: 21193033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptors regulate hepatic F4/80
    Endo-Umeda K; Nakashima H; Komine-Aizawa S; Umeda N; Seki S; Makishima M
    Sci Rep; 2018 Jun; 8(1):9281. PubMed ID: 29915246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
    Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
    Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LXR{beta} is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux.
    Hessvik NP; Boekschoten MV; Baltzersen MA; Kersten S; Xu X; Andersén H; Rustan AC; Thoresen GH
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E602-13. PubMed ID: 19996385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LXR-dependent gene expression is important for macrophage survival and the innate immune response.
    Joseph SB; Bradley MN; Castrillo A; Bruhn KW; Mak PA; Pei L; Hogenesch J; O'connell RM; Cheng G; Saez E; Miller JF; Tontonoz P
    Cell; 2004 Oct; 119(2):299-309. PubMed ID: 15479645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nuclear strike against Listeria--the evolving life of LXR.
    Barish GD; Evans RM
    Cell; 2004 Oct; 119(2):149-51. PubMed ID: 15479632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile.
    Hu X; Steffensen KR; Jiang ZY; Parini P; Gustafsson JÅ; Gåfvels M; Eggertsen G
    J Intern Med; 2012 Nov; 272(5):452-64. PubMed ID: 22329358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
    Jia Y; Hoang MH; Jun HJ; Lee JH; Lee SJ
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4185-90. PubMed ID: 23769638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances on liver X receptors].
    Wang Q; Jiang Y
    Sheng Li Ke Xue Jin Zhan; 2009 Apr; 40(2):147-50. PubMed ID: 19558144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the liver X receptor prevents lipopolysaccharide-induced lung injury.
    Gong H; He J; Lee JH; Mallick E; Gao X; Li S; Homanics GE; Xie W
    J Biol Chem; 2009 Oct; 284(44):30113-21. PubMed ID: 19717840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis.
    Millatt LJ; Bocher V; Fruchart JC; Staels B
    Biochim Biophys Acta; 2003 Mar; 1631(2):107-18. PubMed ID: 12633677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes.
    Volle DH; Repa JJ; Mazur A; Cummins CL; Val P; Henry-Berger J; Caira F; Veyssiere G; Mangelsdorf DJ; Lobaccaro JM
    Mol Endocrinol; 2004 Apr; 18(4):888-98. PubMed ID: 14739254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.
    Pascual-García M; Rué L; León T; Julve J; Carbó JM; Matalonga J; Auer H; Celada A; Escolà-Gil JC; Steffensen KR; Pérez-Navarro E; Valledor AF
    J Immunol; 2013 Jun; 190(12):6520-32. PubMed ID: 23686490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver X receptors bridge hepatic lipid metabolism and inflammation.
    Liu Y; Qiu DK; Ma X
    J Dig Dis; 2012 Feb; 13(2):69-74. PubMed ID: 22257474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.